Research output per year
Research output per year
Project Details
| Short title | A Randomised Phase II Feasibility Study of Docetaxel plus Prednisolone vs Docetaxel plus Prednisolone plus Zoledronic acid vs docetaxel plus Prednisolone plus Strontium-89 vs Docetaxel plus prednisolone plus Zoledronic acid plus Strontium-8 |
|---|---|
| Status | Finished |
| Effective start/end date | 1/12/04 → 31/07/14 |
Funding
- AVENTIS PHARMA LTD
- NOVARTIS PHARMACEUTICALS UK LTD
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Research output
- 1 Article
-
Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747)
Andronis, L., Goranitis, I., Pirrie, S., Pope, A., Barton, D., Collins, S., Daunton, A., McLaren, D., O'Sullivan, J. M., Parker, C., Porfiri, E., Staffurth, J., Stanley, A., Wylie, J., Beesley, S., Birtle, A., Brown, J. E., Chakraborti, P., Hussain, S. A. & Russell, J. M. & 2 others, , Apr 2017, In: BJU international. 119, 4, p. 522-529 8 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile